CHECK CAP LTD (CHEK)

IL0011336851 - Common Stock

2.3  +0.07 (+3.37%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CHEK. CHEK was compared to 192 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for CHEK as it has an excellent financial health rating, but there are worries on the profitability. CHEK has a expensive valuation and it also scores bad on growth.



0

1. Profitability

1.1 Basic Checks

In the past year CHEK has reported negative net income.
In the past year CHEK has reported a negative cash flow from operations.
In the past 5 years CHEK always reported negative net income.
In the past 5 years CHEK always reported negative operating cash flow.

1.2 Ratios

CHEK has a worse Return On Assets (-60.70%) than 76.04% of its industry peers.
With a Return On Equity value of -64.32%, CHEK perfoms like the industry average, outperforming 43.23% of the companies in the same industry.
Industry RankSector Rank
ROA -60.7%
ROE -64.32%
ROIC N/A
ROA(3y)-47.83%
ROA(5y)-71.77%
ROE(3y)-54.92%
ROE(5y)-93.63%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CHEK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

CHEK has more shares outstanding than it did 1 year ago.
CHEK has more shares outstanding than it did 5 years ago.
CHEK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of -2.96, we must say that CHEK is in the distress zone and has some risk of bankruptcy.
CHEK's Altman-Z score of -2.96 is on the low side compared to the rest of the industry. CHEK is outperformed by 65.63% of its industry peers.
CHEK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.96
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

CHEK has a Current Ratio of 17.60. This indicates that CHEK is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 17.60, CHEK belongs to the top of the industry, outperforming 98.96% of the companies in the same industry.
CHEK has a Quick Ratio of 17.60. This indicates that CHEK is financially healthy and has no problem in meeting its short term obligations.
CHEK's Quick ratio of 17.60 is amongst the best of the industry. CHEK outperforms 98.96% of its industry peers.
Industry RankSector Rank
Current Ratio 17.6
Quick Ratio 17.6

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 14.35% over the past year.
EPS 1Y (TTM)14.35%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-1000%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2QN/A

3.2 Future

The Earnings Per Share is expected to grow by 2.75% on average over the next years.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-23.93%
EPS Next 2Y0.62%
EPS Next 3Y2.75%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CHEK. In the last year negative earnings were reported.
Also next year CHEK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.62%
EPS Next 3Y2.75%

0

5. Dividend

5.1 Amount

CHEK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CHECK CAP LTD

NASDAQ:CHEK (5/1/2024, 7:00:00 PM)

2.3

+0.07 (+3.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap13.45M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -60.7%
ROE -64.32%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 17.6
Quick Ratio 17.6
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)14.35%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-23.93%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y